BRIEF-Revive announces completion of rights offering

Mon Jun 20, 2016 8:37am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

June 20 (Reuters) - Revive Therapeutics Ltd :

* Revive announces completion of rights offering for gross proceeds of $844,693 to fund the clinical development of Bucillamine for the treatment of Cystinuria Source text for Eikon: Further company coverage: